Skip to content

A study comparing efficacy of Ayurvedic Ardhodaka Godugdha eye drops and Olopatadine 0.1 Percent eye drops in Allergic conjunctivitis in age group 18-70 years.

A randomised controlled trial to study the efficacy of Ardhodaka Godugdha Aschyotana and Olopatadine 0.1 Percent eye drop in vataja netra abhishyanda (allergic conjunctivitis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/089925
Enrollment
60
Registered
2025-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

None listed

Sponsors

Tilak Ayurved Mahavidyalaya Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants having any three of the above symptoms mentioned in subjective criteria of vataja netrabhishyanda ( allergic conjunctivitis). 2. Participant having age group of 18-70 years irrespective of their gender, caste, economic status & residence status.

Exclusion criteria

Exclusion criteria: 1.Patient with known case of corneal oedema, central corneal ulceration.other ocular pathology (e.g. infective conjunctivtis). 2.Participant with known allergic reaction to sulphur drug or under medication for allergic disorders.

Design outcomes

Primary

MeasureTime frame
decrease in pricking pain , congestion and oedemaTimepoint: 3 day

Secondary

MeasureTime frame
decrease in itching , Eye Discharge , Stiffness of lidsTimepoint: 7 day

Countries

India

Contacts

Public ContactDr Sangeeta santosh Salvi

Tilak Ayurved Mahavidyalaya Pune

salvisangeeta@yahoo.co.in9822082795

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026